UTAH MEDICAL PRODUCTS, INC. (UTMD) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
37/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseUTMD / S&P 11.79% / 15.20% |
LoseUTMD / S&P -7.00% / 15.00% |
LoseUTMD / S&P -12.30% / 50.40% |
| 2026-Q11/3 |
WinUTMD / S&P 11.31% / -4.33% |
LoseUTMD / S&P -4.43% / 11.30% |
LoseUTMD / S&P -10.58% / 27.70% |
| 2025-Q40/3 |
LoseUTMD / S&P -10.65% / 2.65% |
LoseUTMD / S&P -5.83% / 9.00% |
LoseUTMD / S&P -11.90% / 13.40% |
| 2025-Q31/3 |
WinUTMD / S&P 11.17% / 8.12% |
LoseUTMD / S&P -12.35% / 4.61% |
LoseUTMD / S&P -17.10% / 13.45% |
| 2025-Q20/3 |
LoseUTMD / S&P 2.14% / 10.94% |
LoseUTMD / S&P -16.64% / 4.83% |
LoseUTMD / S&P -13.63% / 10.63% |
| 2025-Q10/3 |
LoseUTMD / S&P -8.34% / -4.27% |
LoseUTMD / S&P -19.92% / 4.98% |
LoseUTMD / S&P -16.00% / 10.57% |
| 2024-Q40/3 |
LoseUTMD / S&P -7.68% / 2.41% |
LoseUTMD / S&P -18.56% / 5.25% |
LoseUTMD / S&P -13.57% / 6.15% |
| 2024-Q30/3 |
LoseUTMD / S&P 0.59% / 5.89% |
LoseUTMD / S&P -14.35% / 5.89% |
LoseUTMD / S&P -8.17% / 6.11% |
| 2024-Q20/3 |
LoseUTMD / S&P -5.63% / 4.28% |
LoseUTMD / S&P -10.28% / 5.38% |
LoseUTMD / S&P -8.84% / 5.12% |
| 2024-Q10/3 |
LoseUTMD / S&P -15.20% / 10.56% |
LoseUTMD / S&P -6.54% / 5.71% |
LoseUTMD / S&P -4.66% / 5.59% |
| 2023-Q40/3 |
LoseUTMD / S&P -1.72% / 11.69% |
LoseUTMD / S&P -3.93% / 6.81% |
LoseUTMD / S&P 1.11% / 7.78% |
| 2023-Q31/3 |
LoseUTMD / S&P -7.41% / -3.27% |
LoseUTMD / S&P -0.30% / 7.52% |
WinUTMD / S&P 5.92% / -5.03% |
| 2023-Q21/3 |
LoseUTMD / S&P -1.35% / 8.74% |
LoseUTMD / S&P 1.32% / 9.50% |
WinUTMD / S&P 8.94% / -8.57% |
| 2023-Q11/3 |
LoseUTMD / S&P -5.43% / 7.50% |
LoseUTMD / S&P 4.09% / 10.77% |
WinUTMD / S&P 12.92% / -15.69% |
| 2022-Q42/3 |
WinUTMD / S&P 18.20% / 7.56% |
LoseUTMD / S&P 6.58% / 11.88% |
WinUTMD / S&P 11.60% / -17.99% |
| 2022-Q32/3 |
WinUTMD / S&P -0.35% / -4.88% |
LoseUTMD / S&P 7.21% / 13.47% |
WinUTMD / S&P 14.03% / -1.41% |
| 2022-Q22/3 |
WinUTMD / S&P -4.07% / -16.10% |
LoseUTMD / S&P 11.25% / 13.71% |
WinUTMD / S&P 24.57% / 11.04% |
| 2022-Q12/3 |
LoseUTMD / S&P -9.84% / -4.60% |
WinUTMD / S&P 19.35% / 15.97% |
WinUTMD / S&P 43.15% / 42.23% |
| 2021-Q41/3 |
LoseUTMD / S&P 9.69% / 11.03% |
WinUTMD / S&P 16.30% / 15.00% |
LoseUTMD / S&P 38.23% / 96.40% |
| 2021-Q32/3 |
WinUTMD / S&P 9.51% / 0.58% |
WinUTMD / S&P 14.65% / 10.77% |
LoseUTMD / S&P 21.45% / 69.42% |
| 2021-Q20/3 |
LoseUTMD / S&P -1.46% / 8.55% |
LoseUTMD / S&P 4.64% / 6.58% |
LoseUTMD / S&P 4.17% / 51.81% |
| 2021-Q10/3 |
LoseUTMD / S&P 3.04% / 6.17% |
LoseUTMD / S&P -10.27% / -1.06% |
LoseUTMD / S&P -25.89% / 7.39% |
| 2020-Q41/3 |
LoseUTMD / S&P 5.88% / 12.15% |
LoseUTMD / S&P -10.07% / -3.72% |
WinUTMD / S&P -25.63% / -33.42% |
| 2020-Q31/3 |
LoseUTMD / S&P -9.55% / 8.93% |
LoseUTMD / S&P -6.31% / -2.04% |
WinUTMD / S&P -13.86% / -27.10% |
| 2020-Q22/3 |
LoseUTMD / S&P -5.50% / 20.54% |
WinUTMD / S&P 3.02% / -0.46% |
WinUTMD / S&P -25.17% / -27.11% |
| 2020-Q12/3 |
WinUTMD / S&P -12.56% / -19.60% |
WinUTMD / S&P 12.50% / 3.47% |
LoseUTMD / S&P -16.17% / -14.75% |
| 2019-Q42/3 |
WinUTMD / S&P 12.89% / 9.07% |
WinUTMD / S&P 11.68% / 5.36% |
LoseUTMD / S&P -20.40% / 2.99% |
| 2019-Q32/3 |
LoseUTMD / S&P 0.43% / 1.70% |
WinUTMD / S&P 5.62% / 5.02% |
WinUTMD / S&P 9.20% / 0.21% |
| 2019-Q22/3 |
WinUTMD / S&P 8.81% / 4.30% |
LoseUTMD / S&P 1.29% / 6.64% |
WinUTMD / S&P 76.77% / 8.65% |
| 2019-Q11/3 |
LoseUTMD / S&P 6.57% / 13.65% |
LoseUTMD / S&P -0.47% / 8.12% |
WinUTMD / S&P 93.42% / 14.29% |
| 2018-Q42/3 |
WinUTMD / S&P -11.53% / -13.52% |
LoseUTMD / S&P 1.41% / 9.05% |
WinUTMD / S&P 116.16% / 18.23% |
| 2018-Q30/3 |
LoseUTMD / S&P -14.23% / 7.71% |
LoseUTMD / S&P 5.94% / 10.21% |
LoseUTMD / S&P -8.67% / 19.06% |
| 2018-Q21/3 |
WinUTMD / S&P 11.72% / 3.43% |
LoseUTMD / S&P 6.52% / 9.03% |
LoseUTMD / S&P -27.43% / 14.46% |
| 2018-Q11/3 |
WinUTMD / S&P 21.79% / -0.76% |
LoseUTMD / S&P 7.10% / 7.68% |
LoseUTMD / S&P -26.81% / 12.46% |
| 2017-Q41/3 |
WinUTMD / S&P 11.04% / 6.64% |
LoseUTMD / S&P 5.38% / 7.03% |
LoseUTMD / S&P -28.88% / 13.82% |
| 2017-Q30/3 |
LoseUTMD / S&P 1.96% / 4.48% |
LoseUTMD / S&P 0.09% / 5.68% |
LoseUTMD / S&P 10.48% / 17.57% |
| 2017-Q21/3 |
WinUTMD / S&P 16.66% / 3.09% |
LoseUTMD / S&P -1.79% / 4.83% |
LoseUTMD / S&P 3.86% / 17.74% |
| 2017-Q10/3 |
LoseUTMD / S&P -13.99% / 6.07% |
LoseUTMD / S&P -2.41% / 3.67% |
LoseUTMD / S&P 1.22% / 13.32% |
| 2016-Q41/3 |
WinUTMD / S&P 22.12% / 3.82% |
LoseUTMD / S&P -2.14% / 2.09% |
LoseUTMD / S&P 2.55% / 7.05% |
| 2016-Q31/3 |
LoseUTMD / S&P -4.68% / 3.85% |
LoseUTMD / S&P -1.94% / 0.20% |
WinUTMD / S&P 8.09% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | UTMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 17.72% | 20.78% |
| Annualized return | 17.72% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | UTMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -9.33% | 83.14% |
| Annualized return | -1.94% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | UTMD total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 33.02% | 319.30% |
| Annualized return | 2.89% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |